Role of the Angiogenic Components, VEGFA, FGF2, OPN and RHOC, in Urothelial Cell Carcinoma of the Urinary Bladder

Oncology Reports - Greece
doi 10.3892/or.2012.1948
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

A Case of Nested Variant of Urothelial Carcinoma of the Urinary Bladder

The Journal of the Japanese Society of Clinical Cytology
2012English

Cadmium in Urothelial Carcinoma of the Bladder

Polish Journal of Pathology
MedicineForensic MedicinePathology
2014English

Imp3 Expression in Urothelial Carcinomas of the Urinary Bladder

Turk Patoloji Dergisi
Forensic MedicinePathology
2011English

Imp3 Expression in Urothelial Carcinomas of the Urinary Bladder

Turk Patoloji Dergisi
Forensic MedicinePathology
2011English

Molecular Genetic Evidence for a Common Clonal Origin of Urinary Bladder Small Cell Carcinoma and Coexisting Urothelial Carcinoma

American Journal of Pathology
Forensic MedicinePathology
2005English

Urinary Bladder Carcinoma With Triplicate Differentiations Into Giant Cell Sarcomatoid Carcinoma, Squamous Cell Carcinoma, and Papillary Urothelial Transitional Cell Carcinoma: A Case Report

Cases Journal
2009English

CD10 Expression in Urothelial Carcinoma of the Bladder

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2009English

Urinary Exosomal and Cell-Free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder

Scientific Reports
Multidisciplinary
2018English

Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy